InvestSMART

Clever Culture Systems Limited (ASX: CC5) - Share Price

Current share price for CC5 : $0.021 0.001 (4.55%)+

Clever Culture Systems Limited (CC5, formerly LBT Innovations Limited), an ASX-listed company, is a Company that is engaged in microbiology technology driven by artificial intelligence, delivering modular automation solutions that maximise laboratory efficiency.

CC5 General Information +

ASX Code CC5
Website http://www.cleverculturesystems.com
Industry/Sector Health Care Equipment
Market Cap ($M) 45
CC5 Share Price $0.021
Day High $0.022
Day Low $0.021
Last Close $0.022
CC5 Share Price Movement $0.00 ( 4.55% )
Prices as at 16:40, 23 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Clever Culture Systems Limited (CC5) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Clever Culture Systems Limited (CC5) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Clever Culture Systems Limited (CC5) price-sensitive announcements

CC5 - Quarterly Activities/Appendix 4C Cash Flow Report
Clever Culture Systems Ltd (ASX: CC5) released its quarterly activities and Appendix 4C ca
Clever Culture Systems Limited (CC5)
30 Apr 2026 | 9:46 AM
CC5 - Half Yearly Report and Accounts
Clever Culture Systems Limited, along with its subsidiary Clever Culture Systems AG, repor
Clever Culture Systems Limited (CC5)
17 Feb 2026 | 9:51 AM
CC5 - Quarterly Activities/Appendix 4C Cash Flow Report
Clever Culture Systems Ltd (CCS), an Australian medical technology company, has released i
Clever Culture Systems Limited (CC5)
28 Jan 2026 | 8:19 AM
CC5 - Quarterly Activities/Appendix 4C Cash Flow Report
Clever Culture Systems Ltd, an Australian company specializing in microbiology automation,
Clever Culture Systems Limited (CC5)
30 Oct 2025 | 9:20 AM

Clever Culture Systems Limited (CC5) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Clever Culture Systems Limited (CC5)
ORDINARY FULLY PAID
 Health Care $46 Notification regarding unquoted securities - CC5 23 Jun 2026 8:52AM $0.022 $0.021 fallen by 4.55%
Clever Culture Systems Limited (CC5)
ORDINARY FULLY PAID
 Health Care $46 Updated Company Presentation 23 Jun 2026 8:30AM $0.022 $0.021 fallen by 4.55%
Clever Culture Systems Limited (CC5)
ORDINARY FULLY PAID
 Health Care $46 Proposed issue of securities - CC5 22 Jun 2026 10:54AM $0.022 $0.021 fallen by 2.33%
Clever Culture Systems Limited (CC5)
ORDINARY FULLY PAID
 Health Care $46 CSL Orders APAS Independence for Global QC Operations 9 Jun 2026 9:41AM $0.020 $0.021 risen by 5%
Clever Culture Systems Limited (CC5)
ORDINARY FULLY PAID
 Health Care $46 Sales and Commercial Update 28 May 2026 8:50AM $0.023 $0.021 fallen by 8.70%
Clever Culture Systems Limited (CC5)
ORDINARY FULLY PAID
 Health Care $46 Application for quotation of securities - CC5 13 May 2026 3:49PM $0.023 $0.021 fallen by 8.70%

CC5 Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A $1.68 $0.10 -120.00% 20.00 0.00 0.00% 0.0%
2024A -$3.74 -$0.40 -85.50% 0.00 0.00 0.00% 0.0%
2023A -$9.12 -$2.80 26.60% 0.00 0.00 0.00% 0.0%

CC5 Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Clever Culture Systems Limited (CC5) $50M -1.2000 0.0000 0.0000 28.7500 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear Limited (COH) $7,726M 0.0171 -0.1883 0.0862 19.7417 24.3212 22.3920 3.64% 2.93% 3.13%
Fisher & Paykel Healthcare Corporation Limited (FPH) $18,517M 0.1388 0.1364 0.1884 47.6788 41.9561 35.3040 1.38% 1.47% 1.66%
ResMed Inc. (RMD) $15,239M 0.3087 9.7634 0.0805 183.4938 17.0479 15.7776 1.25% 1.32% 1.39%

CC5 Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.25 27.50 6.88 0.00
Market 0.29 13.20 1.17 0.67
Sector 0.58 22.30 1.61 2.65

CC5 Directors

Name Position Start Date
Mr Brenton John Barnes Chief Executive Officer, Managing Director 9 Aug 2016
Ms Rebecca Jayne Wilson Non-Executive Chairman, Non-Executive Director 3 Jul 2023
Mr Daniel (Dan) Hill Non-Executive Director 14 Dec 2023
Mr Ian Wisenberg Non-Executive Director 1 Oct 2024

Clever Culture Systems Limited (CC5) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
3 Dec 2025 BARNES, Brenton Issued Direct Shares 3,545,581 $0.026 $91,476.000
1 Oct 2025 WILSON, Rebecca Exercise Options 6,798,700 $0.008 $54,389.600
1 Oct 2025 WILSON, Rebecca Issued Indirect Shares 6,798,700 $0.008 $54,389.600

See all changes in directors' interest & trades for Clever Culture Systems Limited (CC5) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CC5 Management

Name Position
Ray Ridge Chief Financial Officer,Company Secretary

CC5 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Clever Culture Systems Limited (CC5). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
283,517,674 (15.62%) Richard Irving Green
223,190,000 (12.30%) Unicore Investments Pty Ltd
212,665,188 (11.72%) Viking Bcm Pty Ltd
100,713,606 (5.55%) Brenton Barnes

CC5 Calendar of Events

Date Event
16 February 2027 Report (Interim)
14 September 2026 Report (Annual)
27 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.